Alkermes (ALKS) Divestments (2015)
Alkermes (ALKS) posted quarterly Divestments of -$301000.0 for Q4 2015, down 1257.69% quarter-over-quarter from $26000.0 in Q3 2015.
Alkermes (ALKS) Divestments (2015) Analysis & Trends
Alkermes (ALKS) has reported Divestments for 1 consecutive years, with -$301000.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Divestments changed N/A year-over-year to -$301000.0; the TTM figure through Sep 2025 stood at -$301000.0 (changed N/A YoY), while the FY2025 annual figure was $1.7 million, down 98.26% from the prior year.
- Divestments slipped to -$301000.0 in Q4 2015 per ALKS's latest filing, from $26000.0 in the prior quarter.
- Across five years, Divestments topped out at $26000.0 in Q3 2015 and bottomed at -$301000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -301,000.00 |
| Sep 30, 2015 | 26,000.00 |